Compile Data Set for Download or QSAR
maximum 50k data
Found 172 Enz. Inhib. hit(s) with all data for entry = 10322
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438983(4-((1R,5S,9s)-9-methoxy-3-((1S,2S)-2-methylcyclobu...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438985(US10604489, Compound 148 | US11180455, Compound 14...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438986(3-((1R,5S,9r)-9-methoxy-34(2-methyl-1H-imidazol-4-...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438988(3-((1R,5S,9r)-9-methoxy-3-(1-phenylazetidin-3-yl)-...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438989(US10604489, Compound 152 | US11180455, Compound 15...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438990(4-((1R,5S,9r)-9-methoxy-3-((5-methyl-1H-imidazol-2...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438991(3-((1R,5S,9r)-3-((1H-indazol-3-yl)methyl)-9-methox...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438992(3-((1R,5S,9r)-3-(but-3-yn-1-yl)-9-methoxy-3-azabic...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438993(US10604489, Compound 156 | US11180455, Compound 15...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438994(3-((1R,5S,9r)-3-(3-fluoropropyl)-9-methoxy-3-azabi...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438996(US10604489, Compound 175 | US11180455, Compound 17...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438997(US10604489, Compound 176 | US11180455, Compound 17...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438998(US10604489, Compound 159 | US11180455, Compound 15...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438844(3-((1R,5S,9r)-3-(4,4-difluorocyclohexyl)-9-methoxy...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438854(4-((1R,5S,9R)-3-((1R,3r,5S)-6,6-difluorobicyclo[3....)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438846(3-((1R,5S,9r)-3-(bicyclo[3.1.0]hexan-3-yl)-9-metho...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438853(3-((1R,5S,9R)-3-((1R,3r,5S)-6,6-difluorobicyclo[3....)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438838(US10604489, Compound 2 | US11180455, Compound 2)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438839(3-((1R,5S,9r)-9-methoxy-3-(2-oxaspiro[3.5]nonan-7-...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438841(3-((1R,5S,9r)-9-methoxy-3-(7-oxaspiro[3.5]nonan-2-...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438844(3-((1R,5S,9r)-3-(4,4-difluorocyclohexyl)-9-methoxy...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438846(3-((1R,5S,9r)-3-(bicyclo[3.1.0]hexan-3-yl)-9-metho...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438845(US10604489, Compound 10 | US11180455, Compound 202)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438849(4-((1R,5S,9r)-9-methoxy-3-(7-oxaspiro[3.5]nonan-2-...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438850(US10604489, Compound 14 | US11180455, Compound 203)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438853(3-((1R,5S,9R)-3-((1R,3r,5S)-6,6-difluorobicyclo[3....)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438854(4-((1R,5S,9R)-3-((1R,3r,5S)-6,6-difluorobicyclo[3....)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438855(US10604489, Compound 19 | US11180455, Compound 19)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438858(3-((1R,5S,9r)-3-benzyl-9-methoxy-3-azabicyclo[3.3....)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438859(3-((1R,5S,9r)-9-methoxy-3-azabicyclo[3.3.1]nonan-9...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438861(3-((1R,5S,9r)-9-methoxy-3-methyl-3-azabicyclo[3.3....)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438862(3-((1R,5S,9r)-9-methoxy-3-phenethyl-3-azabicyclo[3...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438863(3-((1R,5S,9r)-3-isopropyl-9-methoxy-3-azabicyclo[3...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438864(3-benzyl-1,5,3-dioxazepane | US10604489, Compound ...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438867(3-((1R,5S,9r)-3-butyl-9-methoxy-3-azabicyclo[3.3.1...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438868((1R,5S,9r)-3-(cyclopropylmethyl)-9-ethoxy-9-(3-iod...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438872(3-((1R,5S,9r)-9-methoxy-3-(3,3,3-trifluoropropyl)-...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438873((1R,5S,9r)-tert-butyl 9-(3-hydroxphenyl)-9-methoxy...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438874(5-((1R,5S,9r)-3-(cyclopropylmethyl)-9-methoxy-3-az...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438876(3-((1R,5S,9r)-3-cyclopropyl-9-methoxy-3-azabicyclo...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438878(3-((1R,5S,9r)-3-((1-fluorocyclopropyl)methyl)-9-me...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438880(3-((1R,5S,9r)-3-cyclobutyl-9-methoxy-3-azabicyclo[...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438881(4-((1R,5S,9r)-9-methoxy-3-methyl-3-azabicyclo[3.3....)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438884(1-((tetrahydro-2H-pyran-2-yl)oxy)cyclopropanecarbo...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438885(3-((1R,5S,9r)-9-methoxy-3-propyl-3-azabicyclo[3.3....)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438886((1R,5S,9r)-9-(5-bromothiophen-2-yl)-3-methyl-3-aza...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438887(2-hydroxy-3-((1R,5S,9r)-9-methoxy-3-methyl-3-azabi...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438889(3-((1R,5S,9r)-9-methoxy-3-(oxetan-3-ylmethyl)-3-az...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438861(3-((1R,5S,9r)-9-methoxy-3-methyl-3-azabicyclo[3.3....)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM438893((1R,5S)-3-cyclopentyl-3-azaspiro[bicyclo[3.3.1]non...)
Affinity DataKi: <1nMAssay Description:The Ki (binding affinity) for μ-receptor was determined with a previously described method using a competitive displacement assay (Neumeyer et a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 172 total ) | Next | Last >>
Jump to: